Interventional Cardiologist
Erasmus MC Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands
Dr. Joost Daemen obtained his medical degree at the Erasmus University Rotterdam. Between 2005 and 2008, he completed a PhD project entitled “The caveats of drug-eluting stents – a critical appraisal of the safety concerns”. After obtaining his PhD Cum Laude, he commenced his clinical training and interventional cardiology training at the Thorax Center in Rotterdam and at the Insel Spital in Bern, Switzerland. At present, Dr. Daemen is participating in cathlab related activities including complex PCI including the use of left ventricular assist devices, intracoronary imaging, and structural heart interventions. As an associate professor, Dr. Daemen is highly active in cardiovascular research with a specific focus on intracoronary imaging and physiology and renal sympathetic denervation. He co-authored over 300 peer reviewed publications and is a fellow of the European Society of Cardiology (FESC).
Saturday, February 25, 2023
11:44 AM – 12:00 PM ET
Disclosure(s): Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical: Grant/Research Support (Ongoing)
Saturday, February 25, 2023
4:21 PM – 4:38 PM ET
Disclosure(s): Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical: Grant/Research Support (Ongoing)
Sunday, February 26, 2023
10:00 AM – 11:00 AM ET
Disclosure(s): Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical: Grant/Research Support (Ongoing)
Sunday, February 26, 2023
3:00 PM – 4:12 PM ET
Disclosure(s): Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical: Grant/Research Support (Ongoing)
Monday, February 27, 2023
2:00 PM – 2:45 PM ET
Disclosure(s): Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical: Grant/Research Support (Ongoing)
Monday, February 27, 2023
5:00 PM – 6:00 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
5:30 PM – 5:45 PM ET
Disclosure information not submitted.
Monday, February 27, 2023
10:00 AM – 10:48 AM ET
Disclosure(s): Abbott Vascular, Abiomed, ACIST medical, Boston Scientific, Cardialysis BV, CardiacBooster, Kaminari Medical, ReCor Medical, PulseCath, Pie Medical, Sanofi, Siemens Health Care and Medtronic.: Consulting Fees (e.g., advisory boards) (Ongoing); Astra Zeneca, Abbott Vascular, Boston Scientific, ACIST Medical, Medtronic, Microport, Pie Medical, and ReCor medical: Grant/Research Support (Ongoing)